平喘方加减配合布地奈德混悬液雾化吸入治疗小儿哮喘发作期风痰哮证的价值分析

The Value of Pingchuan Fang Addition and Subtraction Combined with Budesonide Suspension Atomization Inhalation in Treating Wind-phlegm Syndrome in Children with Asthmatic Attack

目的:研究平喘方加减配合布地奈德混悬液雾化吸入治疗小儿哮喘发作期风痰哮证的价值。方法:选择2017年10月-2018年10月在笔者所在医院临床治疗的200例哮喘发作期风痰哮证患儿作为本次研究对象,根据其入院顺序分为两组,先入院的100例为对照组,后入院的100例为观察组。观察组实施平喘方加减配合布地奈德混悬液雾化吸入治疗,对照组实施布地奈德混悬液雾化吸入单一治疗,对比两组治疗效果。结果:观察组治疗总有效率高于对照组,差异有统计学意义(χ^2=17.543,P<0.05)。观察组咳嗽、喘息、呼吸困难、哮鸣音消失时间均早于对照组,差异均有统计学意义(t=12.639、18.845、14.066、17.798,P<0.05)。观察组治疗后FVC、FEV1、PEFR水平均高于对照组,差异有统计学意义(t=16.364、13.842、17.381,P<0.05)。观察组不良反应发生率低于对照组,差异有统计学意义(χ^2=25.149,P<0.05)。结论:小儿哮喘发作期风痰哮证采用联合治疗方式,相比单一治疗更具有优势,且安全性高,对改善患儿肺功能指标和早期改善患儿临床症状均具有重大意义,值得研究和推广。

Objective:To study the value of Pingchuan Fang addition and subtraction combined with Budesonide Suspension atomization inhalation in treating wind-phlegm syndrome in children with asthmatic attack.Method:From October 2017 to October 2018,200 children with wind-phlegm syndrome during asthma attack treated in the author’s hospital were selected as the objects of this study.According to their admission sequence,they were divided into two groups,with 100 patients admitted first as the control group and 100 patients admitted later as the observation group.The observation group was treated with Pingchuan Fang addition and subtraction combined with Budesonide Suspension atomization inhalation treatment,while the control group was treated with Budesonide Suspension atomization inhalation single treatment,and the therapeutic effects of the two groups were compared.Result:The total effective rate in the observation group was higher than that in the control group,and the difference was statistically significant (χ^2=17.543,P<0.05).The vanishing time of cough,wheezing,dyspnea and wheezing in the observation group were earlier than those in the control group,the differences were statistically significant (t=12.639,18.845,14.066,17.798,P<0.05).The levels of FVC,FEV1 and PEFR in the observation group were all higher than those in the control group after treatment,the differences were statistically significant (t=16.364,13.842,17.381,P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,the difference was statistically significant (χ^2=25.149,P<0.05).Conclusion:The combined treatment of wind-phlegm syndrome during asthma attack in children has more advantages and higher safety than single treatment,which is of great significance for improving pulmonary function indicators and clinical symptoms in children at early stage,and is worthy of research and promotion.